Yuan-Kun Aden Wu

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan-Kun Aden Wu, An-Li Yu, Mei-Fang Cheng, Lung-Chun Lin, Ming-Jen Lee, Chia-Hung Chou, Chia-Tung Shun, Hsueh-Wen Hsueh, Jimmy Jyh-Ming Juang, Ping-Huei Tseng, Siao-Ping Lin, Mao-Yuan Su, Chi-Chao Chao, Sung-Tsang Hsieh, Cheng-Hsuan Tsai, Yen-Hung Lin
Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis. Therapeutic advances in chronic disease 15 (2024)
Yuan-Kun Aden Wu, An-Li Yu, Mei-Fang Cheng, Lung-Chun Lin, Ming-Jen Lee, Chia-Hung Chou, Chia-Tung Shun, Hsueh-Wen Hsueh, Jimmy Jyh-Ming Juang, Ping-Huei Tseng, Siao-Ping Lin, Mao-Yuan Su, Chi-Chao Chao, Sung-Tsang Hsieh, Cheng-Hsuan Tsai, Yen-Hung Lin
Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis. Therapeutic advances in chronic disease 15 (2024)
Yuan-Kun Aden Wu, Cheng-Hsuan Tsai, Mao-Yuan Su, Chi-Chao Chao, Mei-Fang Cheng, Chia-Tung Shun, Sung-Tsang Hsieh, Yen-Hung Lin
Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment. ESC heart failure (2022)

Yuan-Kun Aden Wu.css-eqlu8i{font-size:small;padding-left:4px;}